Insider Trading & Ownership of Heidi Fields

Location
Santa Clara, CA
Summary
The estimated net worth of Heidi Fields is at least $7,230,895 dollars as of 05 Jun 2025. Heidi Fields is the Director of AGILENT TECHNOLOGIES, INC. and owns shares of AGILENT TECHNOLOGIES, INC. (A) stock worth about $7.13M. Heidi Fields is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $99.3K.
Signature
/s/ Steven Basta, Attorney-in-Fact for Heidi Fields
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Heidi Fields and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Heidi Fields has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $7,230,895.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: AGILENT TECHNOLOGIES, INC. ($7,131,595).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Heidi Fields

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
A AGILENT TECHNOLOGIES, INC. Director $7,131,595 14 Mar 2025
PHAT Phathom Pharmaceuticals, Inc. Director $99,300 03 Jun 2025
ICVX Icosavax, Inc. Former Director $0 19 Feb 2024

Insider Transactions Reported by Heidi Fields:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .